Tonix Pharmaceuticals (TNXP)
NASDAQ:TNXP
Total Valuation
Tonix Pharma has a market cap or net worth of $186.34M. The enterprise value is -$19.99M.
Market Cap$186.34M
Enterprise Value-$19.99M
Share Statistics
Tonix Pharma has 13,405,401 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,405,401
Owned by Insiders0.04%
Owned by Institutions0.78%
Financial Efficiency
Tonix Pharma’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -51.00%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-51.00%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee161.81K
Profits Per Employee-1.53M
Employee Count81
Asset Turnover0.05
Inventory Turnover1.10
Valuation Ratios
The current PE Ratio of Tonix Pharma is ―. Tonix Pharma’s PEG ratio is 0.01.
PE Ratio―
PS Ratio10.14
PB Ratio0.54
Price to Fair Value0.54
Price to FCF-1.29
Price to Operating Cash Flow-1.18
PEG Ratio0.01
Income Statement
In the last 12 months, Tonix Pharma had revenue of 13.11M and earned -124.02M in profits. Earnings per share was -14.57.
Revenue13.11M
Gross Profit6.47M
Operating Income-125.70M
Pretax Income-124.02M
Net Income-124.02M
EBITDA-123.78M
Earnings Per Share (EPS)-14.57
Cash Flow
In the last 12 months, operating cash flow was -99.84M and capital expenditures -5.38M, giving a free cash flow of -105.22M billion.
Operating Cash Flow-99.84M
Free Cash Flow-105.22M
Free Cash Flow per Share-7.85
Dividends & Yields
Tonix Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.54
52-Week Price Change-21.91%
50-Day Moving Average15.13
200-Day Moving Average24.16
Relative Strength Index (RSI)47.66
Average Volume (3m)436.10K
Important Dates
Tonix Pharma upcoming earnings date is May 11, 2026, TBA (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 11, 2026
Ex-Dividend Date―
Financial Position
Tonix Pharma as a current ratio of 7.42, with Debt / Equity ratio of 0.53%
Current Ratio7.42
Quick Ratio7.23
Debt to Market Cap<0.01
Net Debt to EBITDA1.67
Interest Coverage Ratio-1.41K
Taxes
In the past 12 months, Tonix Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tonix Pharma EV to EBITDA ratio is 0.59, with an EV/FCF ratio of 0.71.
EV to Sales-5.60
EV to EBITDA0.59
EV to Free Cash Flow0.71
EV to Operating Cash Flow0.73
Balance Sheet
Tonix Pharma has $207.64M in cash and marketable securities with $1.31M in debt, giving a net cash position of $206.33M billion.
Cash & Marketable Securities$207.64M
Total Debt$1.31M
Net Cash$206.33M
Net Cash Per Share$15.39
Tangible Book Value Per Share$28.79
Margins
Gross margin is 49.34%, with operating margin of -959.05%, and net profit margin of -946.22%.
Gross Margin49.34%
Operating Margin-959.05%
Pretax Margin-946.22%
Net Profit Margin-946.22%
EBITDA Margin-944.37%
EBIT Margin-959.05%
Analyst Forecast
The average price target for Tonix Pharma is $51.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$51.00
Price Target Upside238.20% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-8.79%
EPS Growth Forecast81.36%